PerkinElmer sales and marketing update

PerkinElmer launched its PreeclampsiaScreen T1 serum test in the U.S. to identify asymptomatic patients in the first trimester of pregnancy who are at high risk for developing early onset preeclampsia. The blood test measures three biochemical markers - pregnancy-associated plasma protein A ( PAPPA; pappalysin 1), placental growth factor ( PGF; PlGF) and alpha fetoprotein (AFP) - which provide an individual risk of developing early onset preeclampsia when evaluated collectively with personal demographic data. ...